Impedimed Historical Balance Sheet

IPD Stock

0.05 0 2.00%

Trend analysis of Impedimed balance sheet accounts such as Total Current Liabilities of 4.8 M or Other Liab of 1 M provides information on Impedimed's total assets, liabilities, and equity, which is the actual value of Impedimed to its prevalent stockholders. By breaking down trends over time using Impedimed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Impedimed latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Impedimed is a good buy for the upcoming year.

Impedimed Inventory

912,928

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Impedimed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Impedimed at a specified time, usually calculated after every quarter, six months, or one year. Impedimed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Impedimed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Impedimed currently owns. An asset can also be divided into two categories, current and non-current.

Impedimed Balance Sheet Chart

At this time, Impedimed's Property Plant And Equipment Net is comparatively stable compared to the past year. Cash is likely to gain to about 28.3 M in 2024, whereas Net Receivables is likely to drop slightly above 1.4 M in 2024.

Total Assets Other Current Liab Total Current Liabilities Other Liab Cash

Add Fundamental

Total Assets

Total assets refers to the total amount of Impedimed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Impedimed books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Impedimed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Impedimed are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash

Cash refers to the most liquid asset of Impedimed, which is listed under current asset account on Impedimed balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Impedimed customers. The amounts must be unrestricted with restricted cash listed in a different Impedimed account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most accounts from Impedimed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	3.5M	3.2M	3.2M	3.0M
Total Assets	58.7M	68.7M	47.0M	37.4M

Other Current Liab Total Assets

Impedimed balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Other Liab	Accounts Payable	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding
Total Assets		0.0	0.2	0.3	0.6	0.28	-0.41	0.43	0.63	0.1	0.62	0.26	0.28	0.68	0.28	0.12	0.98	0.34	-0.93	-0.46	0.94	0.31	-0.15	0.94	0.66	0.37
Other Current Liab	0.0		0.94	0.05	0.26	0.22	0.63	0.36	0.18	-0.54	0.32	0.89	0.18	0.03	0.0	-0.24	0.09	0.03	-0.07	-0.1	0.07	0.13	-0.06	0.07	0.11	0.11
Total Current Liabilities	0.2	0.94		0.13	0.52	0.4	0.47	0.58	0.4	-0.57	0.51	0.97	0.35	0.27	0.08	-0.31	0.25	0.15	-0.2	-0.31	0.21	0.27	-0.23	0.21	0.34	0.27
Other Liab	0.3	0.05	0.13		0.03	0.66	-0.11	0.61	0.56	-0.47	0.11	0.3	0.91	0.58	0.94	0.27	0.25	0.87	-0.05	-0.79	0.09	0.96	0.35	0.09	0.42	0.95
Accounts Payable	0.6	0.26	0.52	0.03		0.53	-0.26	0.48	0.66	0.06	0.79	0.49	0.22	0.59	0.0	-0.34	0.54	0.03	-0.52	-0.5	0.52	0.2	-0.29	0.52	0.66	0.24
Other Assets	0.28	0.22	0.4	0.66	0.53		-0.31	0.73	0.85	-0.38	0.63	0.5	0.76	0.79	0.65	-0.01	0.15	0.64	0.01	-0.94	0.01	0.77	0.01	0.01	0.76	0.76
Long Term Debt	-0.41	0.63	0.47	-0.11	-0.26	-0.31		-0.22	-0.39	-0.35	-0.34	0.4	-0.04	-0.61	-0.12	-0.1	-0.21	-0.14	0.19	0.42	-0.18	-0.09	0.19	-0.18	-0.6	-0.17
Net Receivables	0.43	0.36	0.58	0.61	0.48	0.73	-0.22		0.71	-0.63	0.51	0.7	0.8	0.83	0.55	-0.16	0.35	0.65	-0.17	-0.82	0.19	0.73	-0.32	0.19	0.77	0.78
Good Will	0.63	0.18	0.4	0.56	0.66	0.85	-0.39	0.71		-0.27	0.72	0.51	0.67	0.89	0.56	0.11	0.53	0.59	-0.38	-0.88	0.4	0.68	-0.1	0.4	0.89	0.67
Inventory	0.1	-0.54	-0.57	-0.47	0.06	-0.38	-0.35	-0.63	-0.27		-0.08	-0.65	-0.65	-0.27	-0.47	0.14	0.09	-0.51	-0.22	0.43	0.2	-0.56	0.02	0.2	-0.22	-0.54
Other Current Assets	0.62	0.32	0.51	0.11	0.79	0.63	-0.34	0.51	0.72	-0.08		0.53	0.23	0.69	0.18	0.02	0.53	0.27	-0.49	-0.59	0.49	0.24	-0.28	0.49	0.8	0.24
Total Liab	0.26	0.89	0.97	0.3	0.49	0.5	0.4	0.7	0.51	-0.65	0.53		0.51	0.41	0.25	-0.16	0.3	0.35	-0.21	-0.44	0.22	0.43	-0.23	0.22	0.44	0.42
Intangible Assets	0.28	0.18	0.35	0.91	0.22	0.76	-0.04	0.8	0.67	-0.65	0.23	0.51		0.67	0.86	0.09	0.23	0.86	-0.01	-0.86	0.05	0.98	0.08	0.05	0.52	0.97
Common Stock	0.68	0.03	0.27	0.58	0.59	0.79	-0.61	0.83	0.89	-0.27	0.69	0.41	0.67		0.56	0.09	0.54	0.62	-0.38	-0.9	0.39	0.67	-0.22	0.39	0.97	0.71
Property Plant Equipment	0.28	0.0	0.08	0.94	0.0	0.65	-0.12	0.55	0.56	-0.47	0.18	0.25	0.86	0.56		0.4	0.23	0.95	-0.04	-0.77	0.08	0.91	0.38	0.08	0.44	0.87
Short Long Term Debt Total	0.12	-0.24	-0.31	0.27	-0.34	-0.01	-0.1	-0.16	0.11	0.14	0.02	-0.16	0.09	0.09	0.4		0.13	0.45	-0.06	-0.04	0.07	0.17	0.11	0.07	0.04	0.03
Total Stockholder Equity	0.98	0.09	0.25	0.25	0.54	0.15	-0.21	0.35	0.53	0.09	0.53	0.3	0.23	0.54	0.23	0.13		0.29	-0.97	-0.33	0.98	0.25	-0.1	0.98	0.53	0.31
Property Plant And Equipment Net	0.34	0.03	0.15	0.87	0.03	0.64	-0.14	0.65	0.59	-0.51	0.27	0.35	0.86	0.62	0.95	0.45	0.29		-0.09	-0.76	0.13	0.88	0.1	0.13	0.49	0.83
Net Debt	-0.93	-0.07	-0.2	-0.05	-0.52	0.01	0.19	-0.17	-0.38	-0.22	-0.49	-0.21	-0.01	-0.38	-0.04	-0.06	-0.97	-0.09		0.15	-1.0	-0.04	0.11	-1.0	-0.4	-0.1
Retained Earnings	-0.46	-0.1	-0.31	-0.79	-0.5	-0.94	0.42	-0.82	-0.88	0.43	-0.59	-0.44	-0.86	-0.9	-0.77	-0.04	-0.33	-0.76	0.15		-0.17	-0.87	-0.01	-0.17	-0.83	-0.89
Cash	0.94	0.07	0.21	0.09	0.52	0.01	-0.18	0.19	0.4	0.2	0.49	0.22	0.05	0.39	0.08	0.07	0.98	0.13	-1.0	-0.17		0.08	-0.09	1.0	0.4	0.14
Non Current Assets Total	0.31	0.13	0.27	0.96	0.2	0.77	-0.09	0.73	0.68	-0.56	0.24	0.43	0.98	0.67	0.91	0.17	0.25	0.88	-0.04	-0.87	0.08		0.21	0.08	0.52	0.98
Non Currrent Assets Other	-0.15	-0.06	-0.23	0.35	-0.29	0.01	0.19	-0.32	-0.1	0.02	-0.28	-0.23	0.08	-0.22	0.38	0.11	-0.1	0.1	0.11	-0.01	-0.09	0.21		-0.09	-0.21	0.19
Cash And Short Term Investments	0.94	0.07	0.21	0.09	0.52	0.01	-0.18	0.19	0.4	0.2	0.49	0.22	0.05	0.39	0.08	0.07	0.98	0.13	-1.0	-0.17	1.0	0.08	-0.09		0.4	0.14
Common Stock Total Equity	0.66	0.11	0.34	0.42	0.66	0.76	-0.6	0.77	0.89	-0.22	0.8	0.44	0.52	0.97	0.44	0.04	0.53	0.49	-0.4	-0.83	0.4	0.52	-0.21	0.4		0.56
Common Stock Shares Outstanding	0.37	0.11	0.27	0.95	0.24	0.76	-0.17	0.78	0.67	-0.54	0.24	0.42	0.97	0.71	0.87	0.03	0.31	0.83	-0.1	-0.89	0.14	0.98	0.19	0.14	0.56

Click cells to compare fundamentals

Impedimed Account Relationship Matchups

Impedimed balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.1M	34.2M	58.7M	68.7M	47.0M	37.4M
Other Current Liab	2.3M	5.6M	3.5M	3.2M	3.2M	3.0M
Total Current Liabilities	5.1M	8.1M	7.2M	5.8M	4.7M	4.8M
Other Liab	87K	398K	413K	864K	993.6K	1.0M
Accounts Payable	1.9M	1.3M	2.6M	1.4M	1.1M	1.4M
Net Receivables	1.7M	2.8M	2.7M	2.6M	2.2M	1.4M
Good Will	2.6M	2.4M	2.6M	2.7M	2.7M	2.5M
Inventory	864K	372K	926K	810K	759K	912.9K
Other Current Assets	3.3M	2.8M	2.3M	2.8M	1.9M	1.7M
Total Liab	5.7M	8.7M	7.7M	7.9M	6.2M	5.2M
Intangible Assets	6.5M	7.5M	11.4M	14.8M	13.3M	14.0M
Common Stock	250.6M	267.3M	307.6M	336.1M	336.1M	185.5M
Property Plant Equipment	1.0M	1.0M	418K	2.0M	2.2M	2.4M
Total Stockholder Equity	27.4M	25.5M	51.0M	60.9M	40.7M	34.4M
Property Plant And Equipment Net	1.0M	1.0M	418K	2.0M	1.4M	1.5M
Net Debt	(18.8M)	(19.2M)	(40.6M)	(44.3M)	(23.5M)	(24.7M)
Retained Earnings	(250.1M)	(270.8M)	(290.6M)	(311.2M)	(331.0M)	(314.4M)
Cash	19.7M	19.7M	40.7M	45.7M	24.6M	28.3M
Non Current Assets Total	7.6M	8.6M	12.0M	16.8M	17.5M	18.4M
Non Currrent Assets Other	(7.6M)	(8.6M)	(11.9M)	(16.8M)	13.3M	14.0M
Cash And Short Term Investments	19.7M	19.7M	40.7M	45.7M	24.6M	28.3M
Common Stock Shares Outstanding	595.2M	1.2B	1.7B	1.8B	2.0B	2.1B
Liabilities And Stockholders Equity	33.1M	34.2M	58.7M	68.7M	47.0M	39.2M
Non Current Liabilities Total	594K	557K	413K	2.0M	1.6M	1.7M
Property Plant And Equipment Gross	1.0M	3.4M	3.8M	5.6M	5.7M	5.9M
Total Current Assets	25.5M	25.7M	46.7M	51.9M	29.5M	32.8M
Accumulated Other Comprehensive Income	26.9M	29.0M	34.1M	36.0M	35.5M	37.3M
Short Term Debt	364K	(562K)	(758K)	141.0K	333K	349.7K
Net Tangible Assets	20.8M	18.1M	39.7M	46.1M	41.5M	28.0M
Current Deferred Revenue	578K	877K	928K	1.0M	1.5M	1.6M
Long Term Investments	77K	73K	75K	78K	54K	62.5K
Net Invested Capital	27.4M	25.5M	51.0M	60.9M	40.7M	43.5M
Cash And Equivalents	8.8M	11.5M	31.3M	13.5M	12.2M	17.0M
Net Working Capital	20.3M	17.5M	39.4M	46.1M	24.8M	24.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC